In combination with chemotherapy or through administration locally at the tumor site, Nr-CWS prolongs the survival of patients with advanced cancers and increase the levels of cytokines, such as IL-1, IL-6, TNF-α and IFN, in tumor tissue [8]. The gene discussed is IL6; the disease is neoplasm.